Frank Torti
Voorzitter bij IMMUNOVANT, INC.
Vermogen: 10 M $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Frank Torti
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California.
89
| Holding Company | Investment Managers | 89 |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY.
34
| Subsidiary | Pharmaceuticals: Major | 34 |
Public Company | Biotechnology | 28 | |
Private Company | Pharmaceuticals: Major | 24 | |
Public Company | Pharmaceuticals: Major | 22 | |
Point32health Services, Inc.
Point32health Services, Inc. Life/Health InsuranceFinance Tufts Associated Health Plans, Inc. provides healthcare plans. It offers health care coverage options to individuals and employer groups. The firm also offers choice tiered network option plan and Steward Community Choice, a community-based plan, developed in conjunction with Steward Health Care System. The company was founded by Morton A. Madoff in 1979 and is headquartered in Watertown, MA.
19
| Non-Profit Organization | Life/Health Insurance | 19 |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018.
9
| Subsidiary | Biotechnology | 9 |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Immunovant Sciences Ltd.
Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million.
5
| Subsidiary | Biotechnology | 5 |
Subsidiary | Pharmaceuticals: Major | 5 | |
Subsidiary | Biotechnology | 5 | |
Genevant Sciences Corp.
Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
New Enterprise Associates LLC
New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich.
4
| Private Company | Investment Managers | 4 |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Frank Torti via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer Chairman Comptroller/Controller/Auditor Chief Executive Officer President | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member | |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Executive Officer President Chief Executive Officer | |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member Founder Chief Executive Officer Chief Executive Officer | |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Dartmouth College | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Masters Business Admin | |
Point32Health, Inc.
Point32Health, Inc. Miscellaneous Commercial ServicesCommercial Services Point32Health, Inc. is a health and wellbeing organization that provides affordable and high-quality health care to its 2 million members. The non-profit company is based in Watertown, MA, and has subsidiaries in the United States. The company offers a diverse range of health plans that cater to the needs of its members, regardless of their age, race, ethnicity, socioeconomic status, orientation, gender identity, or ability. Point32Health is one of the top twenty health plans in the United States and builds on the quality of its founding organizations, Tufts Health Plan and Harvard Pilgrim Health Care. Cain A. Hayes has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
MERCK & CO., INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
Roivant Social Ventures, Inc. | Director/Board Member Director/Board Member Director/Board Member | ||
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Columbia Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Director/Board Member | |
Stanford Graduate School of Business | College/University | Masters Business Admin Graduate Degree Masters Business Admin | |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Operating Officer | |
TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Corporate Officer/Principal Corporate Officer/Principal | |
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | Founder Private Equity Investor | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
SCYNEXIS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard Law School | College/University | Graduate Degree Graduate Degree | |
QVT Financial LP
QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Portfolio Manager-Equities Analyst-Equity | |
Kriya Therapeutics, Inc.
Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
PHARVARIS N.V. | Pharmaceuticals: Major | Director of Finance/CFO Founder | |
ARCELLX, INC. | Biotechnology | Director/Board Member Director/Board Member | |
NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Founder | |
ADAPTIMMUNE THERAPEUTICS PLC | Biotechnology | Chairman Director/Board Member | |
CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
CAREDX, INC | Medical Specialties | Director/Board Member Director of Finance/CFO | |
TESARO INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Masters Business Admin | |
SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Michigan State University | College/University | Undergraduate Degree Undergraduate Degree | |
HUMACYTE, INC. | Biotechnology | Director/Board Member Chairman | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 42 |
Verenigd Koninkrijk | 5 |
Nederland | 3 |
Zwitserland | 2 |
Canada | 2 |
Sectoraal
Health Technology | 27 |
Consumer Services | 16 |
Finance | 6 |
Commercial Services | 4 |
Operationeel
Director/Board Member | 645 |
Independent Dir/Board Member | 195 |
Corporate Officer/Principal | 182 |
Chief Executive Officer | 101 |
Undergraduate Degree | 87 |
Sterkste connecties
Insiders | |
---|---|
Ed Mathers Mathers | 47 |
David Mott | 45 |
Pierre Legault | 45 |
Jeff Immelt | 41 |
Myrtle Potter | 41 |
Carol Gallagher | 39 |
George Bickerstaff | 37 |
Ali Behbahani | 34 |
Kavita Patel | 30 |
Clarence Machado | 30 |
Ron Bernal | 28 |
Daniel Burgess | 28 |
Kenneth Ludlum | 24 |
Bertram Scott | 24 |
James Robinson | 23 |
- Beurs
- Insiders
- Frank Torti
- Bedrijfsconnecties